Yunlei Cao

ORCID: 0000-0003-4150-1496
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Immunotherapy and Immune Responses

Center for Excellence in Molecular Cell Science
2021-2022

Chinese Academy of Sciences
2021-2022

University of Chinese Academy of Sciences
2022

The cytoplasmic domain of PD-L1 (PD-L1-CD) regulates degradation and stability through various mechanism, making it an attractive target for blocking PD-L1-related cancer signaling. Here, by using NMR biochemical techniques we find that the membrane association PD-L1-CD is mediated electrostatic interactions between acidic phospholipids basic residues in N-terminal region. absence replacement with abolish association. Moreover, basic-to-acidic mutations also decrease cellular abundance...

10.1038/s41467-021-25416-7 article EN cc-by Nature Communications 2021-08-24

Cholesterol, an essential molecule for cell structure, function, and viability, plays crucial roles in the development, progression, survival of cancer cells. Earlier studies have shown that cholesterol-lowering drugs can inhibit high expression programmed-death ligand 1 (PD-L1) contributes to immunoevasion However, regulatory mechanism surface PD-L1 abundance by cholesterol is still controversial. Here, using nuclear magnetic resonance biochemical techniques, we demonstrated directly bind...

10.1126/sciadv.abq4722 article EN cc-by-nc Science Advances 2022-08-26

10.13018/bmr50075 article EN Journal of Back and Musculoskeletal Rehabilitation 2020-04-23
Coming Soon ...